NIH Pharmacogenomics Grants, September — October 2006 | |||
Organization
Name
|
Award |
Principal
Investigator
|
Title
|
University of Texas MD Anderson Cancer Center |
$273,350
|
Abruzzo, Lynne | Validation of RNA and DNA Biomarkers of Prognosis in Chronic Lymphocytic Leukemia |
Columbia University Health Sciences |
$2,180,106
|
Ahsan, Habibul | Genomewide association in early-onset breast cancer |
Source Precision Medicine |
NA
|
Bankaitis-Davis, Danute | Early Prediction of Therapy Responders in Chronic HCV |
Johns Hopkins University |
$781,539
|
Baylin, Stephen | Cancer Genome Characterization Center at Johns Hopkins |
Stanford University |
$391,250
|
Butte, Atul | Enabling new discoveries in pharmacogenomics through a genomic date-driven nosolology |
Cleveland Clinic |
$1,955,979
|
Casey, Graham | Genomic Wide Association Study of Colorectal Cancer |
University of Pennsylvania |
NA
|
Fitzgerald, Garret | Clinical Aspects of Aspirin and Clopidogrel Resistance |
Fred Hutchinson Cancer Research Center |
$796,807
|
Gentleman, Robert | Bioconductor: an open computing resource for genomics |
University of Alabama at Birmingham |
$200,000
|
Guay-Woodford, Lisa | Genetics and Pharmacogenetics in FSGS (PPG Project 4) |
University of California, Los Angeles |
$270,375
|
Hankinson, Oliver | Function and Regulation of Human Cytochrome P4502S1 |
University of Texas Health Science Center |
$315,023
|
Hecht, Jacqueline | Genetic Studies of Clubfoot (ITEV) |
Kovogen |
$130,147
|
Kovoor, Abraham | A Genetic Test for Drug-Induced Dyskinesia Risk |
New York University |
$26,784
|
Listman, Jennifer | Population Genetics & Drug Dependence in Asian Isolates |
Massachusetts Institute of Technology |
$2,387,778
|
Meyerson, Matthew | Center for Cancer Genome Characterization |
University of Arkansas |
$450,491
|
Nowell, Susan | Pharmacogenetics of Hormonal Therapy for Breast Cancer |
University of Kansas Medical Center |
$189,750
|
Reed, Gregory | Probe Drugs for Botanical-Drug Interactions |
Columbia University Health Sciences |
$87,582
|
Shen, Jing | Telomere dysfunction, oxidative damage and breast cancer risk |
DeCode Genetics |
$470,486
|
Stefansson, Kari | Genes Contributing to Opioid Abuse in Humans |
Cold Spring Harbor Laboratory |
$418,750
|
Stein, Lincoln | Enhancing the HapMap Web Site |
Cleveland Clinic |
NA
|
Topol, Eric | Molecular Basis of Resistance to Anti-Platelet Agents |
*SOURCE:
US National Institutes of Health
|